Gray Cameron 4
4 · Cue Biopharma, Inc. · Filed Jun 14, 2018
Insider Transaction Report
Form 4
Gray Cameron
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2018-06-12+8,000→ 8,000 totalExercise: $14.24From: 2018-12-31Exp: 2025-06-12→ Common Stock (8,000 underlying)
Holdings
- 667,500
Common Stock